Skip to content

Sonication of Explanted Breast Implants for Detection of Subclinical Infection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01138891
Enrollment
121
Registered
2010-06-08
Start date
2006-02-28
Completion date
2010-06-30
Last updated
2010-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implants, Breast

Keywords

Breast implants, capsular contraction, sonication, biofilm, Complications, surgery

Brief summary

Objective. Capsular contracture is a frequent complication after breast implantation with unclear etiology. Summary Background Data: Microorganisms may trigger chronic periimplant inflammation with subsequent capsular fibrosis. Study Hypothesis: The investigators hypothesize that with sonication adherent microorganisms can be detected on removed implants . Methods: In a prospective multicentre study all breast implants explanted are collected to be analyzed by sonication. The resulting culture results are correlated with patient, surgical and implant characteristics.

Detailed description

The study is performed in order to find a correlation between the degree of capsular fibrosis and presence of biofilm bacteria on the surface of the implant.

Interventions

None listed

Sponsors

University Hospital, Basel, Switzerland
CollaboratorOTHER
Medical University Innsbruck
CollaboratorOTHER
Clinic Löwencenter, Luzern, Switzerland
CollaboratorUNKNOWN
Clinic Birshof, Münchenstein, Switzerland
CollaboratorUNKNOWN
Crossklinik im Merian Iselin Spital, Basel, Switzerland
CollaboratorUNKNOWN
Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years or more * Undergoing breast implant removal for any reason at one of the participating center * Explantation of breast implant performed between February 2006 and March 2009

Exclusion criteria

* Obvious contamination of the breast implant in the operating room or during transportation.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026